ACE2 expression is also elevated in tumor and tumor-adjacent normal tissues in patients with lung cancer [37,38], which might partially explain why patients with lung cancer are potentially at a higher risk of severe COVID-19. This evidence concerns the gene ACE2 and lung cancer.